Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 31 Jan 20 424B4 Prospectus supplement with pricing info
- 31 Jan 20 EFFECT Notice of effectiveness
-
21 Jan 20 S-1/A IPO registration (amended)
- 6 Jan 20 S-1 IPO registration
ARQT similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the captions “Experts” and “Selected Financial Data” and to the use of our report dated September 9, 2019 (except for the retroactive effect of the 1-for-2 reverse stock split as described in Note 1, as to which the date is January 21, 2020), in Amendment No. 1 to the Registration Statement (Form S-1) and related Prospectus of Arcutis Biotherapeutics, Inc. dated January 21, 2020.
/s/ Ernst & Young LLP
Los Angeles, CA
January 21, 2020